SRI 31215 TFA

SRI 31215 TFA, a triplex inhibitor of matriptase, hepsin and hepatocyte growth factor activator (HGFA) with IC50s of 0.69 μM, 0.65 μM, 0.3 μM, blocks pro-HGF activation and thus mimics the activity of HAI-1/2.


Cat. No.: EX-A3201	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	480	In-stock
100mg	780	In-stock
250mg	1280	In-stock
1g	2650	In-stock
5g	Get quote	inquire

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	SRI 31215 (TFA)
CAS No.	1832686-44-8
Purity	>98%
Formula	C27H34F3N5O3
Mol Weight	533.5858
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Owusu BY, et al. Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling. Oncotarget. 2016 May 17;7(20):29492-506.
CoA	CoA of SRI 31215 TFA

Smiles:	N=C(C1=CC=CC(N2CC(C)CN(CC3CCN(CC4=CC=CC=C4)CC3)C2=O)=C1)N.OC(C(F)(F)F)=O


		Search